News Focus
News Focus
icon url

learningcurve2020

12/04/24 8:17 PM

#735704 RE: flipper44 #735702

So, at least something to look forward to. 
icon url

norisknorewards

12/04/24 8:43 PM

#735706 RE: flipper44 #735702

13f-2. Accordingly, a compliance date of 12 months after the effective date of this release for Rule 13f-2 strikes the appropriate balance between the Commission’s goal of increasing transparency of short sale-related information and providing Managers with adequate time to implement systems and processes to comply with the Rule 13f-2 reporting requirements.425
icon url

Single Stock

12/05/24 3:22 AM

#735731 RE: flipper44 #735702

The vast majority of the our short interest (47.5m) is held by our own warrant holders none of which are institutional or classed as
investment managers. They are in fact more akin to loan sharks . If and when we get to discovery I strongly suspect we will end up
with a fair amount of egg on our chin.

I cut Les off years ago due to his insistence of spouting rubbish about illegal naked short positions, he even said the fake shares were issued
in China , my good god ... utter freakin liability . Funnily enough he'd dropped that by the time of the pleadings .

I have live available to borrow data live on my system, there are always at least 300k+ that are quickly replenished if they are borrowed
and the number normally actually hovers at an average of 600-700k . With a daily average volume of 2m , 600k is too much to absorb .

Remember the shear elation on this board when our `white knight` SIO (aka loan shark) became our first institutional investor, then the exact amount of shares they bought were put up to lend,many of us complained and SIO kindly withdrew them and then of course dumped them ...

Its a story of years of rinse-repeat, and of course all of the above contributes to a net net result of 28c.

We were spoofed many many times , but all stocks are simply check any board the same complaints are heard, but with journals and data to boot we are the ones at $364m on OTCQB a level where biotech startups are after the second round of raises and I have no doubt who's fault that is ...